Double-Punch attack on colon cancer before surgery
NCT ID NCT06368141
Summary
This study is testing a two-step treatment for people with locally advanced colon cancer. First, patients receive standard chemotherapy. Then, they receive the same chemotherapy combined with an immunotherapy drug (Serplulimab) before having surgery. Researchers want to see if this approach helps destroy more of the cancer before it's removed and improves long-term survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ruijin Hospital
RECRUITINGShanghai, Shanghai Municipality, 200025, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.